Safety Study of Microneedle Patch With Tetanus Vaccine Booster
Part of Infections clinical trials.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 16 years old and in generally good health
- You have a clear, healthy patch of skin (at least 1 inch × 1 inch) on your inner forearm with no rashes, scars, tattoos, or skin conditions
- You have not received a tetanus booster vaccine in the past 12 months
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You are not currently taking immune-suppressing medications (like systemic steroids or biologic drugs)
- You can attend all study visits and follow all study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This trial tests a new injection (SNA02-48) designed to protect adults who are at high risk of tetanus infection. Tetanus is a serious bacterial infection that can cause severe muscle stiffness and life-threatening complications; this study evaluates whether this new protective treatment is safe and effective.
This study looks at how well a tetanus booster vaccine works by testing your saliva and blood. It includes healthy children, young adults, pregnant women, and adults with certain medical conditions.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.